Evidence map›Paper›PMID 21156794›Full record

ArticleThe Journal of biological chemistry2011

MTA1 coregulation of transglutaminase 2 expression and function during inflammatory response.

Krishna Sumanth Ghanta, Suresh B Pakala, Sirigiri Divijendra Natha Reddy, Da-Qiang Li, Sujit S Nair, Rakesh Kumar

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Transglutaminases in Monocytes and Macrophages.Medical sciences (Basel, Switzerland) · 2018
    Review
  12. Article
  13. Review
  14. Review
  15. MTA1 regulation of ERβ pathway in salivary gland carcinoma cells.Biochemical and biophysical research communications · 2015
    Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Breast tumor and stromal cell responses to TGF-β and hypoxia in matrix deposition.Matrix biology : journal of the International Society for Matrix Biology · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Krishna Sumanth GhantaDepartment of Biochemistry and Molecular Biology and Institute of Coregulator Biology, The George Washington University Medical Center, Washington, DC 20037, USA.
Suresh B Pakala
Sirigiri Divijendra Natha Reddy
Da-Qiang Li
Sujit S Nair
Rakesh Kumar
George Washington University · USWashington University Medical Center · US

Funding

Role of Metastatic Tumor Antigen-1 in Mammary GlandR01CA098823 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KUMAR, RAKESH · 2003 to 2013
$3.1M
NCI NIH HHS CA98823NCI NIH HHS CA98823-S1NCI NIH HHS R01 CA098823
6 · The paper itself

Abstract

Although both metastatic tumor antigen 1 (MTA1), a master chromatin modifier, and transglutaminase 2 (TG2), a multifunctional enzyme, are known to be activated during inflammation, it remains unknown whether these molecules regulate inflammatory response in a coordinated manner. Here we investigated the role of MTA1 in the regulation of TG2 expression in bacterial lipopolysaccharide (LPS)-stimulated mammalian cells. While studying the impact of MTA1 status on global gene expression, we unexpectedly discovered that MTA1 depletion impairs the basal as well as the LPS-induced expression of TG2 in multiple experimental systems. We found that TG2 is a chromatin target of MTA1 and of NF-κB signaling in LPS-stimulated cells. In addition, LPS-mediated stimulation of TG2 expression is accompanied by the enhanced recruitment of MTA1, p65RelA, and RNA polymerase II to the NF-κB consensus sites in the TG2 promoter. Interestingly, both the recruitment of p65 and TG2 expression are effectively blocked by a pharmacological inhibitor of the NF-κB pathway. These findings reveal an obligatory coregulatory role of MTA1 in the regulation of TG2 expression and of the MTA1-TG2 pathway, at least in part, in LPS modulation of the NF-κB signaling in stimulated macrophages.

Indexed as

AnimalsBreast NeoplasmsCell Line, TumorChromatin ImmunoprecipitationFemaleFibroblastsGene Expression Regulation, EnzymologicGTP-Binding ProteinsHistone DeacetylasesHumansInflammationLipopolysaccharidesMacrophages, PeritonealMiceNF-kappa BProtein Glutamine gamma Glutamyltransferase 2GTP-Binding ProteinsHistone DeacetylasesLipopolysaccharidesMTA1 protein, humanMta1 protein, mouseNF-kappa BProtein Glutamine gamma Glutamyltransferase 2Repressor ProteinsTrans-ActivatorsTranscription FactorsTransglutaminases

Identifiers

PMID21156794
PMCPMC3044970
OpenAlexW2050251713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.